Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

BACKGROUND: Adenovirus serotype 5 (Ad5) is a commonly used viral vector for transient delivery of transgenes, primarily for vaccination against pathogen and tumor antigens. However, endemic infections with Ad5 produce virus-specific neutralizing antibodies (NAbs) that limit transgene delivery and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Flickinger Jr, John C, Singh, Jagmohan, Carlson, Robert, Leong, Elinor, Baybutt, Trevor R, Barton, Joshua, Caparosa, Ellen, Pattison, Amanda, Rappaport, Jeffrey A, Roh, Jamin, Zhan, Tingting, Bashir, Babar, Waldman, Scott A, Snook, Adam E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443303/
https://www.ncbi.nlm.nih.gov/pubmed/32819976
http://dx.doi.org/10.1136/jitc-2020-001046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443303/
https://www.ncbi.nlm.nih.gov/pubmed/32819976
http://dx.doi.org/10.1136/jitc-2020-001046

Ejemplares similares